COVID-19 Outbreak-Global Flu (Influenza) Vaccine Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
The Flu (Influenza) Vaccine market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Flu (Influenza) Vaccine industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Flu (Influenza) Vaccine market can be split based on product types, major applications, and important countries as follows:
Key players in the global Flu (Influenza) Vaccine market covered in Chapter 12:
GlaxoSmithKline
CSL (Novartis)
Pfizer
Inovio Pharmaceuticals
Novavax
Bavarian Nordic
Emergent BioSolutions
Merck & Co
Mitsubishi Tanabe Pharma
Sanofi Pasteur
In Chapter 4 and 14.1, on the basis of types, the Flu (Influenza) Vaccine market from 2015 to 2025 is primarily split into:
Inactivated Influenza Vaccines (IIV)
Live Attenuated Influenza Vaccines (LAIV)
In Chapter 5 and 14.2, on the basis of applications, the Flu (Influenza) Vaccine market from 2015 to 2025 covers:
For Children (6 months to 3 years)
For Adults and Children over 3 years
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Flu (Influenza) Vaccine industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Flu (Influenza) Vaccine market can be split based on product types, major applications, and important countries as follows:
Key players in the global Flu (Influenza) Vaccine market covered in Chapter 12:
GlaxoSmithKline
CSL (Novartis)
Pfizer
Inovio Pharmaceuticals
Novavax
Bavarian Nordic
Emergent BioSolutions
Merck & Co
Mitsubishi Tanabe Pharma
Sanofi Pasteur
In Chapter 4 and 14.1, on the basis of types, the Flu (Influenza) Vaccine market from 2015 to 2025 is primarily split into:
Inactivated Influenza Vaccines (IIV)
Live Attenuated Influenza Vaccines (LAIV)
In Chapter 5 and 14.2, on the basis of applications, the Flu (Influenza) Vaccine market from 2015 to 2025 covers:
For Children (6 months to 3 years)
For Adults and Children over 3 years
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 FLU (INFLUENZA) VACCINE INTRODUCTION AND MARKET OVERVIEW
1.1 Objectives of the Study
1.2 Overview of Flu (Influenza) Vaccine
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Flu (Influenza) Vaccine industry
1.4 Methodology of The Study
1.5 Research Data Source
2 EXECUTIVE SUMMARY
2.1 Market Overview
2.1.1 Global Flu (Influenza) Vaccine Market Size, 2015 – 2020
2.1.2 Global Flu (Influenza) Vaccine Market Size by Type, 2015 – 2020
2.1.3 Global Flu (Influenza) Vaccine Market Size by Application, 2015 – 2020
2.1.4 Global Flu (Influenza) Vaccine Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Flu (Influenza) Vaccine Industry Development
3 INDUSTRY CHAIN ANALYSIS
3.1 Upstream Raw Material Suppliers of Flu (Influenza) Vaccine Analysis
3.2 Major Players of Flu (Influenza) Vaccine
3.3 Flu (Influenza) Vaccine Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Flu (Influenza) Vaccine
3.3.3 Labor Cost of Flu (Influenza) Vaccine
3.4 Market Distributors of Flu (Influenza) Vaccine
3.5 Major Downstream Buyers of Flu (Influenza) Vaccine Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 GLOBAL FLU (INFLUENZA) VACCINE MARKET, BY TYPE
4.1 Global Flu (Influenza) Vaccine Value and Market Share by Type (2015-2020)
4.2 Global Flu (Influenza) Vaccine Production and Market Share by Type (2015-2020)
4.3 Global Flu (Influenza) Vaccine Value and Growth Rate by Type (2015-2020)
4.3.1 Global Flu (Influenza) Vaccine Value and Growth Rate of Inactivated Influenza Vaccines (IIV)
4.3.2 Global Flu (Influenza) Vaccine Value and Growth Rate of Live Attenuated Influenza Vaccines (LAIV)
4.4 Global Flu (Influenza) Vaccine Price Analysis by Type (2015-2020)
5 FLU (INFLUENZA) VACCINE MARKET, BY APPLICATION
5.1 Downstream Market Overview
5.2 Global Flu (Influenza) Vaccine Consumption and Market Share by Application (2015-2020)
5.3 Global Flu (Influenza) Vaccine Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Flu (Influenza) Vaccine Consumption and Growth Rate of For Children (6 months to 3 years) (2015-2020)
5.3.2 Global Flu (Influenza) Vaccine Consumption and Growth Rate of For Adults and Children over 3 years (2015-2020)
6 GLOBAL FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY REGIONS
6.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Regions
6.1.1 Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)
6.1.2 Global Flu (Influenza) Vaccine Revenue by Regions (2015-2020)
6.2 North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.3 Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.6 South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7 NORTH AMERICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY COUNTRIES
7.1 The Influence of COVID-19 on North America Market
7.2 North America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
7.2.1 North America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
7.2.2 North America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
7.3 United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.4 Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.5 Mexico Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8 EUROPE FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY COUNTRIES
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
8.2.1 Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020)
8.2.2 Europe Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
8.3 Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.4 UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.5 France Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.6 Italy Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.7 Spain Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.8 Russia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9 ASIA PACIFIC FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY COUNTRIES
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Flu (Influenza) Vaccine Sales by Countries (2015-2020)
9.2.2 Asia Pacific Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
9.3 China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.4 Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.5 South Korea Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.6 India Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.8 Australia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10 MIDDLE EAST AND AFRICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY COUNTRIES
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Flu (Influenza) Vaccine Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
10.3 Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.4 UAE Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.5 Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.6 Nigeria Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.7 South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
11 SOUTH AMERICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY COUNTRIES
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
11.2.1 South America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
11.2.2 South America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
11.3 Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
11.4 Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
11.5 Columbia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
11.6 Chile Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
12 COMPETITIVE LANDSCAPE
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Basic Information
12.1.2 Flu (Influenza) Vaccine Product Introduction
12.1.3 GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020
12.2 CSL (Novartis)
12.2.1 CSL (Novartis) Basic Information
12.2.2 Flu (Influenza) Vaccine Product Introduction
12.2.3 CSL (Novartis) Production, Value, Price, Gross Margin 2015-2020
12.3 Pfizer
12.3.1 Pfizer Basic Information
12.3.2 Flu (Influenza) Vaccine Product Introduction
12.3.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.4 Inovio Pharmaceuticals
12.4.1 Inovio Pharmaceuticals Basic Information
12.4.2 Flu (Influenza) Vaccine Product Introduction
12.4.3 Inovio Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.5 Novavax
12.5.1 Novavax Basic Information
12.5.2 Flu (Influenza) Vaccine Product Introduction
12.5.3 Novavax Production, Value, Price, Gross Margin 2015-2020
12.6 Bavarian Nordic
12.6.1 Bavarian Nordic Basic Information
12.6.2 Flu (Influenza) Vaccine Product Introduction
12.6.3 Bavarian Nordic Production, Value, Price, Gross Margin 2015-2020
12.7 Emergent BioSolutions
12.7.1 Emergent BioSolutions Basic Information
12.7.2 Flu (Influenza) Vaccine Product Introduction
12.7.3 Emergent BioSolutions Production, Value, Price, Gross Margin 2015-2020
12.8 Merck & Co
12.8.1 Merck & Co Basic Information
12.8.2 Flu (Influenza) Vaccine Product Introduction
12.8.3 Merck & Co Production, Value, Price, Gross Margin 2015-2020
12.9 Mitsubishi Tanabe Pharma
12.9.1 Mitsubishi Tanabe Pharma Basic Information
12.9.2 Flu (Influenza) Vaccine Product Introduction
12.9.3 Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2015-2020
12.10 Sanofi Pasteur
12.10.1 Sanofi Pasteur Basic Information
12.10.2 Flu (Influenza) Vaccine Product Introduction
12.10.3 Sanofi Pasteur Production, Value, Price, Gross Margin 2015-2020
13 INDUSTRY OUTLOOK
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 GLOBAL FLU (INFLUENZA) VACCINE MARKET FORECAST
14.1 Global Flu (Influenza) Vaccine Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Inactivated Influenza Vaccines (IIV) Market Value and Volume Forecast (2020-2025)
14.1.2 Live Attenuated Influenza Vaccines (LAIV) Market Value and Volume Forecast (2020-2025)
14.2 Global Flu (Influenza) Vaccine Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 For Children (6 months to 3 years) Market Value and Volume Forecast (2020-2025)
14.2.2 For Adults and Children over 3 years Market Value and Volume Forecast (2020-2025)
14.3 Flu (Influenza) Vaccine Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 NEW PROJECT FEASIBILITY ANALYSIS
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
1.1 Objectives of the Study
1.2 Overview of Flu (Influenza) Vaccine
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Flu (Influenza) Vaccine industry
1.4 Methodology of The Study
1.5 Research Data Source
2 EXECUTIVE SUMMARY
2.1 Market Overview
2.1.1 Global Flu (Influenza) Vaccine Market Size, 2015 – 2020
2.1.2 Global Flu (Influenza) Vaccine Market Size by Type, 2015 – 2020
2.1.3 Global Flu (Influenza) Vaccine Market Size by Application, 2015 – 2020
2.1.4 Global Flu (Influenza) Vaccine Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Flu (Influenza) Vaccine Industry Development
3 INDUSTRY CHAIN ANALYSIS
3.1 Upstream Raw Material Suppliers of Flu (Influenza) Vaccine Analysis
3.2 Major Players of Flu (Influenza) Vaccine
3.3 Flu (Influenza) Vaccine Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Flu (Influenza) Vaccine
3.3.3 Labor Cost of Flu (Influenza) Vaccine
3.4 Market Distributors of Flu (Influenza) Vaccine
3.5 Major Downstream Buyers of Flu (Influenza) Vaccine Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 GLOBAL FLU (INFLUENZA) VACCINE MARKET, BY TYPE
4.1 Global Flu (Influenza) Vaccine Value and Market Share by Type (2015-2020)
4.2 Global Flu (Influenza) Vaccine Production and Market Share by Type (2015-2020)
4.3 Global Flu (Influenza) Vaccine Value and Growth Rate by Type (2015-2020)
4.3.1 Global Flu (Influenza) Vaccine Value and Growth Rate of Inactivated Influenza Vaccines (IIV)
4.3.2 Global Flu (Influenza) Vaccine Value and Growth Rate of Live Attenuated Influenza Vaccines (LAIV)
4.4 Global Flu (Influenza) Vaccine Price Analysis by Type (2015-2020)
5 FLU (INFLUENZA) VACCINE MARKET, BY APPLICATION
5.1 Downstream Market Overview
5.2 Global Flu (Influenza) Vaccine Consumption and Market Share by Application (2015-2020)
5.3 Global Flu (Influenza) Vaccine Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Flu (Influenza) Vaccine Consumption and Growth Rate of For Children (6 months to 3 years) (2015-2020)
5.3.2 Global Flu (Influenza) Vaccine Consumption and Growth Rate of For Adults and Children over 3 years (2015-2020)
6 GLOBAL FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY REGIONS
6.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Regions
6.1.1 Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)
6.1.2 Global Flu (Influenza) Vaccine Revenue by Regions (2015-2020)
6.2 North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.3 Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.6 South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7 NORTH AMERICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY COUNTRIES
7.1 The Influence of COVID-19 on North America Market
7.2 North America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
7.2.1 North America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
7.2.2 North America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
7.3 United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.4 Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.5 Mexico Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8 EUROPE FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY COUNTRIES
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
8.2.1 Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020)
8.2.2 Europe Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
8.3 Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.4 UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.5 France Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.6 Italy Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.7 Spain Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.8 Russia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9 ASIA PACIFIC FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY COUNTRIES
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Flu (Influenza) Vaccine Sales by Countries (2015-2020)
9.2.2 Asia Pacific Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
9.3 China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.4 Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.5 South Korea Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.6 India Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.8 Australia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10 MIDDLE EAST AND AFRICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY COUNTRIES
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Flu (Influenza) Vaccine Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
10.3 Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.4 UAE Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.5 Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.6 Nigeria Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.7 South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
11 SOUTH AMERICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS BY COUNTRIES
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
11.2.1 South America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
11.2.2 South America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
11.3 Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
11.4 Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
11.5 Columbia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
11.6 Chile Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
12 COMPETITIVE LANDSCAPE
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Basic Information
12.1.2 Flu (Influenza) Vaccine Product Introduction
12.1.3 GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020
12.2 CSL (Novartis)
12.2.1 CSL (Novartis) Basic Information
12.2.2 Flu (Influenza) Vaccine Product Introduction
12.2.3 CSL (Novartis) Production, Value, Price, Gross Margin 2015-2020
12.3 Pfizer
12.3.1 Pfizer Basic Information
12.3.2 Flu (Influenza) Vaccine Product Introduction
12.3.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.4 Inovio Pharmaceuticals
12.4.1 Inovio Pharmaceuticals Basic Information
12.4.2 Flu (Influenza) Vaccine Product Introduction
12.4.3 Inovio Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.5 Novavax
12.5.1 Novavax Basic Information
12.5.2 Flu (Influenza) Vaccine Product Introduction
12.5.3 Novavax Production, Value, Price, Gross Margin 2015-2020
12.6 Bavarian Nordic
12.6.1 Bavarian Nordic Basic Information
12.6.2 Flu (Influenza) Vaccine Product Introduction
12.6.3 Bavarian Nordic Production, Value, Price, Gross Margin 2015-2020
12.7 Emergent BioSolutions
12.7.1 Emergent BioSolutions Basic Information
12.7.2 Flu (Influenza) Vaccine Product Introduction
12.7.3 Emergent BioSolutions Production, Value, Price, Gross Margin 2015-2020
12.8 Merck & Co
12.8.1 Merck & Co Basic Information
12.8.2 Flu (Influenza) Vaccine Product Introduction
12.8.3 Merck & Co Production, Value, Price, Gross Margin 2015-2020
12.9 Mitsubishi Tanabe Pharma
12.9.1 Mitsubishi Tanabe Pharma Basic Information
12.9.2 Flu (Influenza) Vaccine Product Introduction
12.9.3 Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2015-2020
12.10 Sanofi Pasteur
12.10.1 Sanofi Pasteur Basic Information
12.10.2 Flu (Influenza) Vaccine Product Introduction
12.10.3 Sanofi Pasteur Production, Value, Price, Gross Margin 2015-2020
13 INDUSTRY OUTLOOK
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 GLOBAL FLU (INFLUENZA) VACCINE MARKET FORECAST
14.1 Global Flu (Influenza) Vaccine Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Inactivated Influenza Vaccines (IIV) Market Value and Volume Forecast (2020-2025)
14.1.2 Live Attenuated Influenza Vaccines (LAIV) Market Value and Volume Forecast (2020-2025)
14.2 Global Flu (Influenza) Vaccine Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 For Children (6 months to 3 years) Market Value and Volume Forecast (2020-2025)
14.2.2 For Adults and Children over 3 years Market Value and Volume Forecast (2020-2025)
14.3 Flu (Influenza) Vaccine Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 NEW PROJECT FEASIBILITY ANALYSIS
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
LIST OF TABLES AND FIGURES
Figure Product Picture of Flu (Influenza) Vaccine
Table Product Specification of Flu (Influenza) Vaccine
Table Flu (Influenza) Vaccine Key Market Segments
Table Key Players Flu (Influenza) Vaccine Covered
Figure Global Flu (Influenza) Vaccine Market Size, 2015 – 2025
Table Different Types of Flu (Influenza) Vaccine
Figure Global Flu (Influenza) Vaccine Value ($) Segment by Type from 2015-2020
Figure Global Flu (Influenza) Vaccine Market Share by Types in 2019
Table Different Applications of Flu (Influenza) Vaccine
Figure Global Flu (Influenza) Vaccine Value ($) Segment by Applications from 2015-2020
Figure Global Flu (Influenza) Vaccine Market Share by Applications in 2019
Figure Global Flu (Influenza) Vaccine Market Share by Regions in 2019
Figure North America Flu (Influenza) Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure Europe Flu (Influenza) Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Flu (Influenza) Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Flu (Influenza) Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure South America Flu (Influenza) Vaccine Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Flu (Influenza) Vaccine
Table Upstream Raw Material Suppliers of Flu (Influenza) Vaccine with Contact Information
Table Major Players Headquarters, and Service Area of Flu (Influenza) Vaccine
Figure Major Players Production Value Market Share of Flu (Influenza) Vaccine in 2019
Table Major Players Flu (Influenza) Vaccine Product Types in 2019
Figure Production Process of Flu (Influenza) Vaccine
Figure Manufacturing Cost Structure of Flu (Influenza) Vaccine
Figure Channel Status of Flu (Influenza) Vaccine
Table Major Distributors of Flu (Influenza) Vaccine with Contact Information
Table Major Downstream Buyers of Flu (Influenza) Vaccine with Contact Information
Table Global Flu (Influenza) Vaccine Value ($) by Type (2015-2020)
Table Global Flu (Influenza) Vaccine Value Share by Type (2015-2020)
Figure Global Flu (Influenza) Vaccine Value Share by Type (2015-2020)
Table Global Flu (Influenza) Vaccine Production by Type (2015-2020)
Table Global Flu (Influenza) Vaccine Production Share by Type (2015-2020)
Figure Global Flu (Influenza) Vaccine Production Share by Type (2015-2020)
Figure Global Flu (Influenza) Vaccine Value ($) and Growth Rate of Inactivated Influenza Vaccines (IIV) (2015-2020)
Figure Global Flu (Influenza) Vaccine Value ($) and Growth Rate of Live Attenuated Influenza Vaccines (LAIV) (2015-2020)
Figure Global Flu (Influenza) Vaccine Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Flu (Influenza) Vaccine Consumption by Application (2015-2020)
Table Global Flu (Influenza) Vaccine Consumption Market Share by Application (2015-2020)
Figure Global Flu (Influenza) Vaccine Consumption Market Share by Application (2015-2020)
Figure Global Flu (Influenza) Vaccine Consumption and Growth Rate of For Children (6 months to 3 years) (2015-2020)
Figure Global Flu (Influenza) Vaccine Consumption and Growth Rate of For Adults and Children over 3 years (2015-2020)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Global Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Sales Market Share by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue (M USD) by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2015
Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2019
Figure North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table North America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
Table North America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table North America Flu (Influenza) Vaccine Revenue (M USD) by Countries (2015-2020)
Table North America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Mexico Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020)
Table Europe Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table Europe Flu (Influenza) Vaccine Revenue (M USD) by Countries (2015-2020)
Table Europe Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure France Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Italy Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Spain Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Russia Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Flu (Influenza) Vaccine Sales by Countries (2015-2020)
Table Asia Pacific Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table Asia Pacific Flu (Influenza) Vaccine Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure South Korea Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure India Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Southeast Asia Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Australia Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Middle East Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table Middle East Flu (Influenza) Vaccine Sales by Countries (2015-2020)
Table Middle East and Africa Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Flu (Influenza) Vaccine Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure UAE Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Egypt Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Nigeria Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure South Africa Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure South America Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table South America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
Table South America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table South America Flu (Influenza) Vaccine Revenue (M USD) by Countries (2015-2020)
Table South America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Columbia Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Chile Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Top 3 Market Share of Flu (Influenza) Vaccine Companies in 2019
Figure Top 6 Market Share of Flu (Influenza) Vaccine Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Product Introduction
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Value ($) Market Share 2015-2020
Table CSL (Novartis) Profile
Table CSL (Novartis) Product Introduction
Figure CSL (Novartis) Production and Growth Rate
Figure CSL (Novartis) Value ($) Market Share 2015-2020
Table Pfizer Profile
Table Pfizer Product Introduction
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Inovio Pharmaceuticals Profile
Table Inovio Pharmaceuticals Product Introduction
Figure Inovio Pharmaceuticals Production and Growth Rate
Figure Inovio Pharmaceuticals Value ($) Market Share 2015-2020
Table Novavax Profile
Table Novavax Product Introduction
Figure Novavax Production and Growth Rate
Figure Novavax Value ($) Market Share 2015-2020
Table Bavarian Nordic Profile
Table Bavarian Nordic Product Introduction
Figure Bavarian Nordic Production and Growth Rate
Figure Bavarian Nordic Value ($) Market Share 2015-2020
Table Emergent BioSolutions Profile
Table Emergent BioSolutions Product Introduction
Figure Emergent BioSolutions Production and Growth Rate
Figure Emergent BioSolutions Value ($) Market Share 2015-2020
Table Merck & Co Profile
Table Merck & Co Product Introduction
Figure Merck & Co Production and Growth Rate
Figure Merck & Co Value ($) Market Share 2015-2020
Table Mitsubishi Tanabe Pharma Profile
Table Mitsubishi Tanabe Pharma Product Introduction
Figure Mitsubishi Tanabe Pharma Production and Growth Rate
Figure Mitsubishi Tanabe Pharma Value ($) Market Share 2015-2020
Table Sanofi Pasteur Profile
Table Sanofi Pasteur Product Introduction
Figure Sanofi Pasteur Production and Growth Rate
Figure Sanofi Pasteur Value ($) Market Share 2015-2020
Table Market Driving Factors of Flu (Influenza) Vaccine
Table Merger, Acquisition and New Investment
Table Global Flu (Influenza) Vaccine Market Value ($) Forecast, by Type
Table Global Flu (Influenza) Vaccine Market Volume Forecast, by Type
Figure Global Flu (Influenza) Vaccine Market Value ($) and Growth Rate Forecast of Inactivated Influenza Vaccines (IIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Market Volume ($) and Growth Rate Forecast of Inactivated Influenza Vaccines (IIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Market Value ($) and Growth Rate Forecast of Live Attenuated Influenza Vaccines (LAIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Market Volume ($) and Growth Rate Forecast of Live Attenuated Influenza Vaccines (LAIV) (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of For Children (6 months to 3 years) (2020-2025)
Figure Market Volume and Growth Rate Forecast of For Children (6 months to 3 years) (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of For Adults and Children over 3 years (2020-2025)
Figure Market Volume and Growth Rate Forecast of For Adults and Children over 3 years (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Figure Product Picture of Flu (Influenza) Vaccine
Table Product Specification of Flu (Influenza) Vaccine
Table Flu (Influenza) Vaccine Key Market Segments
Table Key Players Flu (Influenza) Vaccine Covered
Figure Global Flu (Influenza) Vaccine Market Size, 2015 – 2025
Table Different Types of Flu (Influenza) Vaccine
Figure Global Flu (Influenza) Vaccine Value ($) Segment by Type from 2015-2020
Figure Global Flu (Influenza) Vaccine Market Share by Types in 2019
Table Different Applications of Flu (Influenza) Vaccine
Figure Global Flu (Influenza) Vaccine Value ($) Segment by Applications from 2015-2020
Figure Global Flu (Influenza) Vaccine Market Share by Applications in 2019
Figure Global Flu (Influenza) Vaccine Market Share by Regions in 2019
Figure North America Flu (Influenza) Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure Europe Flu (Influenza) Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Flu (Influenza) Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Flu (Influenza) Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure South America Flu (Influenza) Vaccine Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Flu (Influenza) Vaccine
Table Upstream Raw Material Suppliers of Flu (Influenza) Vaccine with Contact Information
Table Major Players Headquarters, and Service Area of Flu (Influenza) Vaccine
Figure Major Players Production Value Market Share of Flu (Influenza) Vaccine in 2019
Table Major Players Flu (Influenza) Vaccine Product Types in 2019
Figure Production Process of Flu (Influenza) Vaccine
Figure Manufacturing Cost Structure of Flu (Influenza) Vaccine
Figure Channel Status of Flu (Influenza) Vaccine
Table Major Distributors of Flu (Influenza) Vaccine with Contact Information
Table Major Downstream Buyers of Flu (Influenza) Vaccine with Contact Information
Table Global Flu (Influenza) Vaccine Value ($) by Type (2015-2020)
Table Global Flu (Influenza) Vaccine Value Share by Type (2015-2020)
Figure Global Flu (Influenza) Vaccine Value Share by Type (2015-2020)
Table Global Flu (Influenza) Vaccine Production by Type (2015-2020)
Table Global Flu (Influenza) Vaccine Production Share by Type (2015-2020)
Figure Global Flu (Influenza) Vaccine Production Share by Type (2015-2020)
Figure Global Flu (Influenza) Vaccine Value ($) and Growth Rate of Inactivated Influenza Vaccines (IIV) (2015-2020)
Figure Global Flu (Influenza) Vaccine Value ($) and Growth Rate of Live Attenuated Influenza Vaccines (LAIV) (2015-2020)
Figure Global Flu (Influenza) Vaccine Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Flu (Influenza) Vaccine Consumption by Application (2015-2020)
Table Global Flu (Influenza) Vaccine Consumption Market Share by Application (2015-2020)
Figure Global Flu (Influenza) Vaccine Consumption Market Share by Application (2015-2020)
Figure Global Flu (Influenza) Vaccine Consumption and Growth Rate of For Children (6 months to 3 years) (2015-2020)
Figure Global Flu (Influenza) Vaccine Consumption and Growth Rate of For Adults and Children over 3 years (2015-2020)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Global Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Sales Market Share by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue (M USD) by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2015
Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2019
Figure North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table North America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
Table North America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table North America Flu (Influenza) Vaccine Revenue (M USD) by Countries (2015-2020)
Table North America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Mexico Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020)
Table Europe Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table Europe Flu (Influenza) Vaccine Revenue (M USD) by Countries (2015-2020)
Table Europe Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure France Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Italy Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Spain Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Russia Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Flu (Influenza) Vaccine Sales by Countries (2015-2020)
Table Asia Pacific Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table Asia Pacific Flu (Influenza) Vaccine Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure South Korea Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure India Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Southeast Asia Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Australia Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Middle East Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table Middle East Flu (Influenza) Vaccine Sales by Countries (2015-2020)
Table Middle East and Africa Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Flu (Influenza) Vaccine Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure UAE Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Egypt Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Nigeria Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure South Africa Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure South America Flu (Influenza) Vaccine Revenue (M USD) and Growth (2015-2020)
Table South America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
Table South America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table South America Flu (Influenza) Vaccine Revenue (M USD) by Countries (2015-2020)
Table South America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure Columbia Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Chile Flu (Influenza) Vaccine Sales and Growth (2015-2020)
Figure Top 3 Market Share of Flu (Influenza) Vaccine Companies in 2019
Figure Top 6 Market Share of Flu (Influenza) Vaccine Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Product Introduction
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Value ($) Market Share 2015-2020
Table CSL (Novartis) Profile
Table CSL (Novartis) Product Introduction
Figure CSL (Novartis) Production and Growth Rate
Figure CSL (Novartis) Value ($) Market Share 2015-2020
Table Pfizer Profile
Table Pfizer Product Introduction
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Inovio Pharmaceuticals Profile
Table Inovio Pharmaceuticals Product Introduction
Figure Inovio Pharmaceuticals Production and Growth Rate
Figure Inovio Pharmaceuticals Value ($) Market Share 2015-2020
Table Novavax Profile
Table Novavax Product Introduction
Figure Novavax Production and Growth Rate
Figure Novavax Value ($) Market Share 2015-2020
Table Bavarian Nordic Profile
Table Bavarian Nordic Product Introduction
Figure Bavarian Nordic Production and Growth Rate
Figure Bavarian Nordic Value ($) Market Share 2015-2020
Table Emergent BioSolutions Profile
Table Emergent BioSolutions Product Introduction
Figure Emergent BioSolutions Production and Growth Rate
Figure Emergent BioSolutions Value ($) Market Share 2015-2020
Table Merck & Co Profile
Table Merck & Co Product Introduction
Figure Merck & Co Production and Growth Rate
Figure Merck & Co Value ($) Market Share 2015-2020
Table Mitsubishi Tanabe Pharma Profile
Table Mitsubishi Tanabe Pharma Product Introduction
Figure Mitsubishi Tanabe Pharma Production and Growth Rate
Figure Mitsubishi Tanabe Pharma Value ($) Market Share 2015-2020
Table Sanofi Pasteur Profile
Table Sanofi Pasteur Product Introduction
Figure Sanofi Pasteur Production and Growth Rate
Figure Sanofi Pasteur Value ($) Market Share 2015-2020
Table Market Driving Factors of Flu (Influenza) Vaccine
Table Merger, Acquisition and New Investment
Table Global Flu (Influenza) Vaccine Market Value ($) Forecast, by Type
Table Global Flu (Influenza) Vaccine Market Volume Forecast, by Type
Figure Global Flu (Influenza) Vaccine Market Value ($) and Growth Rate Forecast of Inactivated Influenza Vaccines (IIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Market Volume ($) and Growth Rate Forecast of Inactivated Influenza Vaccines (IIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Market Value ($) and Growth Rate Forecast of Live Attenuated Influenza Vaccines (LAIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Market Volume ($) and Growth Rate Forecast of Live Attenuated Influenza Vaccines (LAIV) (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of For Children (6 months to 3 years) (2020-2025)
Figure Market Volume and Growth Rate Forecast of For Children (6 months to 3 years) (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of For Adults and Children over 3 years (2020-2025)
Figure Market Volume and Growth Rate Forecast of For Adults and Children over 3 years (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
